A large-scale analysis involving Dr Bilal Mateen (UCL Institute of Health Informatics) has found a disproportionately higher Covid-19 death risk in middle-aged people with type 2 diabetes, raising questions over vaccination strategies across Europe.
Read: Times (£), More: UCL News
Close
